As of 2026-08-12, the EV/EBITDA ratio of Britannia Life Sciences Inc (BLAB.CN) is -3.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLAB.CN's latest enterprise value is 9.83 mil CAD. BLAB.CN's TTM EBITDA according to its financial statements is -2.47 mil CAD. Dividing these 2 quantities gives us the above BLAB.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-08-06 | -3.98 |
| 2026-08-05 | -4.34 |
| 2026-07-31 | -4.34 |
| 2026-07-29 | -3.98 |
| 2026-07-28 | -3.98 |
| 2026-07-27 | -3.98 |
| 2026-07-24 | -3.98 |
| 2026-07-22 | -4.34 |
| 2026-07-21 | -3.98 |
| 2026-07-20 | -4.34 |
| 2026-07-17 | -4.34 |
| 2026-07-16 | -3.98 |
| 2026-07-14 | -4.34 |
| 2026-07-08 | -4.34 |
| 2026-07-07 | -4.34 |
| 2026-07-06 | -4.70 |
| 2026-07-02 | -4.70 |
| 2026-06-29 | -4.70 |
| 2026-06-23 | -4.70 |
| 2026-06-22 | -4.70 |
| 2026-06-19 | -4.70 |
| 2026-06-18 | -5.05 |
| 2026-06-16 | -5.05 |
| 2026-06-15 | -5.05 |
| 2026-06-12 | -5.41 |
| 2026-06-11 | -5.05 |
| 2026-06-10 | -4.70 |
| 2026-06-09 | -4.70 |
| 2026-06-05 | -5.41 |
| 2026-06-04 | -5.41 |
| 2026-06-02 | -5.76 |
| 2026-05-29 | -5.41 |
| 2026-05-26 | -5.76 |
| 2026-05-22 | -5.76 |
| 2026-05-21 | -5.76 |
| 2026-05-20 | -5.41 |
| 2026-05-15 | -5.41 |
| 2026-05-14 | -5.76 |
| 2026-05-13 | -5.41 |
| 2026-05-12 | -5.41 |